Marcaine/epinephrine Pf Coupons & Savings Card – Discount Prices from $1.01

When considering the use of Marcaine with Epinephrine, it's important to be aware of several safety concerns:

Cardiac Arrest in Obstetrical Anesthesia: The 0.75% concentration of Marcaine has been linked to cardiac arrest and death during epidural anesthesia in obstetrical patients. Therefore, this concentration is not recommended for obstetrical anesthesia and should be reserved for surgical procedures requiring significant muscle relaxation and prolonged effect.

Methemoglobinemia Risk: Use of local anesthetics like Marcaine can lead to methemoglobinemia, a condition where the blood's ability to carry oxygen is reduced. Individuals with certain health conditions, such as glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, or those under six months of age, are at higher risk. Symptoms may include skin discoloration and abnormal blood color. Immediate treatment is necessary to prevent severe complications.

Chondrolysis with Intra-Articular Infusion: The use of Marcaine for continuous infusion into joints following surgical procedures is not approved. There have been reports of chondrolysis, a severe joint condition, particularly in the shoulder, associated with this practice. Symptoms like joint pain and stiffness can appear as early as two months post-surgery, and effective treatments are currently lacking.

Allergic Reactions to Sulfites: Marcaine with Epinephrine contains sodium metabisulfite, which can cause allergic reactions, including severe asthmatic episodes, in susceptible individuals. Those with asthma are more likely to experience such reactions.

Use in Areas with Limited Blood Supply: Caution is advised when using Marcaine with Epinephrine in body areas with limited blood supply, such as fingers, toes, nose, ears, or the penis. The vasoconstrictive properties of epinephrine can lead to ischemic injury or tissue death in these regions.

Risk of Cardiac Arrest with Intravenous Regional Anesthesia (Bier Block): There have been reports of cardiac arrest and death when using bupivacaine, the active ingredient in Marcaine, for intravenous regional anesthesia. Due to insufficient information on safe dosages and techniques for this procedure, its use is contraindicated.

Risk of Respiratory Arrest in Ophthalmic Surgery: Respiratory arrest has been reported following the use of local anesthetics like Marcaine in eye surgeries. It's crucial to have resuscitative equipment and trained personnel available when performing such procedures.

Risk of Adverse Reactions in Head and Neck Areas: Injections of local anesthetics into the head and neck can lead to serious adverse reactions, including confusion, convulsions, and respiratory depression. These may result from unintended intravascular injections or nerve sheath punctures. Careful monitoring and immediate availability of resuscitative measures are essential.

Risk of Toxicity in Patients with Hepatic Impairment: Since bupivacaine is metabolized by the liver, patients with moderate to severe liver impairment may be at increased risk of toxicity. Reduced dosing and enhanced monitoring are recommended for these individuals.

Risk of Use in Patients with Impaired Cardiovascular Function: Patients with cardiovascular issues, such as hypotension or heart block, may be less able to compensate for the effects of Marcaine with Epinephrine. Reduced doses and close monitoring of blood pressure, heart rate, and ECG are advised.

Risk of Systemic Toxicities with Unintended Intravascular or Intrathecal Injection: Accidental injection into blood vessels or the spinal canal can lead to severe systemic toxicities, including central nervous system or cardiorespiratory depression, and even coma. Aspirating for blood or cerebrospinal fluid before each dose and considering a test dose can help mitigate this risk.

Risk of Cardiac Arrhythmias with Concomitant Use of Potent Inhalation Anesthetics: Using Marcaine with Epinephrine alongside potent inhalation anesthetics can result in serious, dose-related cardiac arrhythmias. Careful consideration of the combined effects on the heart is necessary when these agents are used together.

Risk of Inadvertent Trauma in Dental Applications: Due to the prolonged numbness caused by Marcaine with Epinephrine, patients may unintentionally injure their tongue, lips, or inner cheeks after dental procedures. It's important to avoid chewing solid foods until sensation returns.

Risk of Adverse Reactions Due to Drug Interactions: Concurrent use of Marcaine with Epinephrine and certain medications, such as monoamine oxidase inhibitors, tricyclic antidepressants, ergot-type oxytocic drugs, or nonselective beta-adrenergic antagonists, can lead to severe and prolonged hypertension or other serious cardiovascular effects. Such combinations should generally be avoided, and if necessary, require careful monitoring.

Use in Specific Populations: The safety and effectiveness of Marcaine with Epinephrine in pediatric patients under 12 years have not been established, and its use is not recommended in this age group. Elderly patients, especially those with hypertension, may be at increased risk of developing hypotension during anesthesia with this medication. Patients with severe liver impairment are at greater risk of developing toxic plasma concentrations due to reduced metabolism of the drug.

Given these potential risks, it's crucial for healthcare providers to assess each patient's individual circumstances and medical history before administering Marcaine with Epinephrine.

Marcaine with Epinephrine PF is a local anesthetic used to numb specific areas during medical procedures. While effective, it can cause side effects ranging from mild to severe. Common Side Effects:

• Injection Site Reactions: Pain, redness, or swelling where the injection was administered.
• Back Pain: Some individuals may experience discomfort in the back following the procedure. Serious Side Effects:
• Central Nervous System (CNS) Effects: Symptoms may include restlessness, anxiety, dizziness, tinnitus (ringing in the ears), blurred vision, tremors, convulsions, drowsiness, unconsciousness, respiratory arrest, nausea, vomiting, chills, and pupillary constriction.
• Cardiovascular Effects: High doses or unintentional intravascular injection can lead to depression of the myocardium, decreased cardiac output, heart block, hypotension, bradycardia, ventricular arrhythmias (including ventricular tachycardia and ventricular fibrillation), and cardiac arrest.
• Allergic Reactions: Signs include urticaria (hives), pruritus (itching), erythema (redness), angioneurotic edema (swelling, including of the larynx), tachycardia (rapid heartbeat), sneezing, nausea, vomiting, dizziness, syncope (fainting), excessive sweating, elevated temperature, and severe hypotension (low blood pressure).
• Methemoglobinemia: A rare but serious condition where oxygen delivery to tissues is impaired, leading to cyanotic skin discoloration and/or abnormal coloration of the blood. Immediate treatment is required to prevent severe complications. Drug Interactions:
• Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants: Concurrent use may result in severe, prolonged hypertension.
• Ergot-Type Oxytocic Drugs: Combined use can cause severe, persistent hypertension or cerebrovascular accidents.
• Nonselective Beta-Adrenergic Antagonists: May lead to severe hypertension and bradycardia when used with Marcaine with Epinephrine PF. Special Considerations:
• Sulfite Sensitivity: This medication contains sodium metabisulfite, which may cause allergic-type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible individuals.
• Use in Specific Populations: Elderly patients, particularly those with hypertension, may be at increased risk for developing hypotension during anesthesia. Patients with severe hepatic impairment are at greater risk of developing toxic plasma concentrations. Those with renal impairment may also have an increased risk of adverse reactions. It's crucial to inform your healthcare provider of all medications you're taking and any existing health conditions before receiving Marcaine with Epinephrine PF. If you experience any severe side effects or signs of an allergic reaction, seek immediate medical attention.

When using Marcaine with Epinephrine, it's important to be aware of potential interactions with other medications:

• Other Local Anesthetics: Combining Marcaine with other local anesthetics can increase the risk of toxic effects. If such combinations are necessary, patients should be closely monitored for signs of nervous system and heart-related side effects.

• Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants: Using Marcaine with Epinephrine alongside these antidepressants may lead to severe and prolonged high blood pressure. It's generally advised to avoid this combination. If it's unavoidable, careful monitoring of the patient's blood pressure and heart function is essential.

• Ergot-Type Oxytocic Drugs: Concurrent use with these drugs can cause serious, persistent high blood pressure or even strokes. Therefore, it's recommended to avoid using Marcaine with Epinephrine with ergot-type oxytocic drugs.

• Nonselective Beta-Blockers: Combining these medications can result in severe high blood pressure and slow heart rate. This combination should generally be avoided. If necessary, the patient's blood pressure and heart rate should be closely monitored.

• Drugs Associated with Methemoglobinemia: Certain medications, including some antibiotics, antimalarials, and other local anesthetics, can increase the risk of methemoglobinemia—a condition where oxygen delivery to tissues is impaired. Patients receiving Marcaine with Epinephrine should be monitored for signs of this condition if they're also taking these drugs.

• Potent Inhalation Anesthetics: Using Marcaine with Epinephrine during or after administration of strong inhaled anesthetics can lead to serious heart rhythm problems. Caution is advised when these are used together.

• Phenothiazines and Butyrophenones: These medications may reduce or reverse the blood pressure-raising effects of epinephrine. Concurrent use with Marcaine with Epinephrine should generally be avoided. If necessary, careful patient monitoring is essential.

Always inform your healthcare provider about all medications you're currently taking to ensure safe and effective use of Marcaine with Epinephrine.